Invention Grant
- Patent Title: Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
-
Application No.: US17194224Application Date: 2021-03-06
-
Publication No.: US11872274B2Publication Date: 2024-01-16
- Inventor: Emilio Anthony Emini , Wendy Jo Watson , Avvari Krishna Prasad , Mingming Han , Jin-Hwan Kim , Jianxin Gu , Yu-Ying Yang , Rajesh Kumar Kainthan , David Cooper , Michael William Pride , Kathrin Ute Jansen
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Carol A. Mckeever
- The original application number of the division: US16899738 2020.06.12
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/09 ; A61K47/64
Abstract:
The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates) and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions.
Public/Granted literature
- US20210196810A1 Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof Public/Granted day:2021-07-01
Information query
